Manuscripts
Showing 1533 manuscripts.
Correlation between circulating stromal cell-derived factor 1 levels and CD4+ cell count in human immunodeficiency virus type 1-infected individuals
Citation
Cynthia A. Derdeyn, Caroline Costello, J. Michael Kilby, Greg Sfakianos, Michael Switow Saag, Richard Kaslow, R. Pat Bucy. Correlation between circulating stromal cell-derived factor 1 levels and CD4+ cell count in human immunodeficiency virus type 1-infected individuals. AIDS Research and Human Retroviruses. 1999. 15: 1063-71.Year
1999
Journal
AIDS Research and Human Retroviruses
Natural history of intestinal microsporidiosis among patients infected with human immunodeficiency virus
Citation
K. Dascomb, Rebecca Adair Clark, Judith A. Aberg, Joseph J. Pulvirenti, Ross G. Hewitt, Patty Kissinger, Elizabeth Didier. Natural history of intestinal microsporidiosis among patients infected with human immunodeficiency virus. Journal of Clinical Microbiology. 1999. 37: 3421-2.Year
1999
Journal
Journal of Clinical Microbiology
Absolute Copy Number and Relative Change in Determinations of Human Immunodeficiency Virus Type 1 RNA in Plasma: Effect of an External Standard on Kit Comparisons.
Citation
Donald Brambilla, Sheila Leung, Judy Lew, John Todd, Steven Herman, Mike Cronin, David E. Shapiro, James Bremer, Celine Hanson, George V. Hillyer, George D. McSherry, Rhoda S. Sperling, Robert W. Coombs, Patricia S. Reichelderfer. Absolute Copy Number and Relative Change in Determinations of Human Immunodeficiency Virus Type 1 RNA in Plasma: Effect of an External Standard on Kit Comparisons.. Journal of Clinical Microbiology. 1998. 36: 311-314.Year
1998
Journal
Journal of Clinical Microbiology
Eradication of AIDS-related disseminated mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy
Citation
Judith A. Aberg, David M. Yajko, Mark A. Jacobson. Eradication of AIDS-related disseminated mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy. Journal of Infectious Diseases. 1998. 178: 1446-9.Year
1998
Journal
Journal of Infectious Diseases
Human immunodeficiency virus type 1 RNA shedding in the female genital tract
Citation
Claudia Goulston, W. McFarland, David Katzenstein. Human immunodeficiency virus type 1 RNA shedding in the female genital tract. Journal of Infectious Diseases. 1998. 177: 1100-3.Year
1998
Journal
Journal of Infectious Diseases
Interlaboratory concordance of DNA sequence analysis to detect drug reverse transciptase mutations in HIV-1 proviral DNA
Citation
Patricia Reichelderfer, Anthony Japour, Lisa M. Demeter, Richard D'Aquila, Owen Weislow, Alejo Erice, Joseph Fitzgibbon, Robert Shafer, Douglas Richman, Yuqi Zhao, Diana Huang, Douglas Mayers, Max Arens, Kim Sannerud, Suraiya Rasheed, Daniel Kuritzkes. Interlaboratory concordance of DNA sequence analysis to detect drug reverse transciptase mutations in HIV-1 proviral DNA. Journal of Virological Methods. 1998. 75: 93-104.Year
1998
Journal
Journal of Virological Methods
Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS
Citation
G. Widmer, S. Tzipori, Carl J. Fichtenbaum, Jeff Griffiths. Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS. Journal of Infectious Diseases. 1998. 178: 834-40.Year
1998
Journal
Journal of Infectious Diseases
Maternal Viral Genotypic Zidovudine Resistance and Infrequent Failure of Zidovudine Therapy to Prevent Perinatal Transmission of HIV-1 in Pediatric AIDS Clinical Trials Group Protocol 076
Citation
P. S. Eastman, David E. Shapiro, Robert W. Coombs, Lisa M. Frenkel, George D. McSherry, Paula Britto, Steven A. Herman, Rhoda S. Sperling. Maternal Viral Genotypic Zidovudine Resistance and Infrequent Failure of Zidovudine Therapy to Prevent Perinatal Transmission of HIV-1 in Pediatric AIDS Clinical Trials Group Protocol 076. Journal of Infectious Diseases. 1998. 177: 557-64.Year
1998
Journal
Journal of Infectious Diseases
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
Citation
Frank Palella, K. M. Delaney, A. C. Moorman, Mark O. Loveless, Jack Fuhrer, G. A. Satten, D. J. Aschman, S. D. Holmberg. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine. 1998. 338: 853-60.Year
1998
Journal
New England Journal of Medicine
Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor
Citation
David J. Straus, Jenny Huang, Marcia A. Testa, Alexandra M. Levine, Lawrence D. Kaplan. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. Journal of Clinical Oncology. 1998. 16: 3601-6.Year
1998
Journal
Journal of Clinical Oncology